Brief: Immunovant Reports Positive Initial Phase 2 Results For Batoclimab In Graves’ Disease

Immunovant

20/12/2023 23:03

Dec 20 (Reuters) - Immunovant Inc  IMVT.O :
    * IMMUNOVANT REPORTS POSITIVE INITIAL PHASE 2 RESULTS FOR
BATOCLIMAB IN GRAVES’ DISEASE
    * IMMUNOVANT INC - BATOCLIMAB WAS GENERALLY WELL TOLERATED
WITH NO
NEW SAFETY SIGNALS OBSERVED IN INITIAL DATA SET
    * IMMUNOVANT - INTEND TO FOCUS FUTURE DEVELOPMENT IN GRAVES'
ON
IMVT-1402, WITH PLANS EXPECTED TO BE ANNOUNCED LATER IN 2024

Source text for Eikon:  ID:nGNX81L0Ck 
Further company coverage:  IMVT.O 

 ((Reuters.Briefs@thomsonreuters.com;))